4.8 Article

Bioinspired Diselenide-Bridged Mesoporous Silica Nanoparticles for Dual-Responsive Protein Delivery

期刊

ADVANCED MATERIALS
卷 30, 期 29, 页码 -

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/adma.201801198

关键词

biodegradable mesoporous silica nanoparticles; cancer-cell-membrane cloaking; diselenide; dual-responsive; protein delivery

资金

  1. National Natural Science Foundation of China [81601609, 81771982, 61535010, 81371681, 8160071152]
  2. NIH [HL109442, AI096305, 1UG3TR002142, GM110494]
  3. Guangdong Innovative and Entrepreneurial Research Team Program [2013S086]
  4. Global Research Laboratory Program (Korean NSF GRL) [2015032163]
  5. National Key Research and Development Program of China [2017YFF0108600, 2016YFF0103800]
  6. National Research Foundation of Korea [2015K1A1A2032163] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

Controlled delivery of protein therapeutics remains a challenge. Here, the inclusion of diselenide-bond-containing organosilica moieties into the framework of silica to fabricate biodegradable mesoporous silica nanoparticles (MSNs) with oxidative and redox dual-responsiveness is reported. These diselenide-bridged MSNs can encapsulate cytotoxic RNase A into the 8-10 nm internal pores via electrostatic interaction and release the payload via a matrix-degradation controlled mechanism upon exposure to oxidative or redox conditions. After surface cloaking with cancer-cell-derived membrane fragments, these bioinspired RNase A-loaded MSNs exhibit homologous targeting and immune-invasion characteristics inherited from the source cancer cells. The efficient in vitro and in vivo anti-cancer performance, which includes increased blood circulation time and enhanced tumor accumulation along with low toxicity, suggests that these cell-membrane-coated, dual-responsive degradable MSNs represent a promising platform for the delivery of bio-macromolecules such as protein and nucleic acid therapeutics.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据